Systematic review of preclinical, clinical, and post-marketing evidence of bupropion misuse potential

References

• Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor. Prim Care Companion J Clin Psychiatry. 2004;6(4):159–66.
   PubMedGoogle Scholar
• Mulholland A. Doctors warn of potentially fatal abuse of Wellbutrin antidepressant. CTV News [Internet]; 2013 [accessed 2017 Sep 17]. http://www.ctvnews.ca/health/health-headlines/doctors-warn-of-potentially-fatal-abuse-of-wellbutrin-antidepressant-1.1383282.
   Google Scholar
• Erowid. Erowid Experience Vaults 2017 [ accessed 2017 Sep 14]. https://erowid.org/experiences/subs/exp_Pharms_Bupropion.shtml.
   Google Scholar
• Shalabi AR, Walther D, Baumann MH, Glennon RA. Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release. ACS Chem Neurosci. 2017;8(6):1397–403. doi:10.1021/acschemneuro.7b00055.
   PubMed Web of Science ®Google Scholar
• Fleckenstein AE, Hanson GR. Impact of psychostimulants on vesicular monoamine transporter function. Eur J Pharmacol. 2003;479(1–3):283–89.
   PubMed Web of Science ®Google Scholar
• Rau KS, Birdsall E, Hanson JE, Johnson-Davis KL, Carroll FI, Wilkins DG, Gibb JW, Hanson GR, Fleckenstein AE. Bupropion increases striatal vesicular monoamine transport. Neuropharmacology. 2005;49(6):820–30. doi:10.1016/j.neuropharm.2005.05.004.
   PubMed Web of Science ®Google Scholar
• Lp D, As R, Ka K-P, Mt B. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev. 2006;12(3–4):178–207. doi:10.1111/j.1527-3458.2006.00178.x.
   PubMedGoogle Scholar
• Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR. New Insights into the Mechanism of Action of Amphetamines. Annu Rev Pharmacol Toxicol. 2007;47(1):681–98. doi:10.1146/annurev.pharmtox.47.120505.105140.
   PubMed Web of Science ®Google Scholar
• Heal DJ, Smith SL, Gosden J, Nutt DJ. Amphetamine, past and present – a pharmacological and clinical perspective. J Psychopharmacol. 2013;27(6):479–96. doi:10.1177/0269881113482532.
   PubMed Web of Science ®Google Scholar
• Huskinson SL, Naylor JE, Rowlett JK, Freeman KB. Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations. Neuropharmacology. 2014;87:66–80. doi:10.1016/j.neuropharm.2014.03.009.
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKline. Wellbutrin(R) [package insert] Research Triangle Park, NC2004
   Google Scholar
• Cooper BR, Hester TJ, Maxwell RA. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther. 1980;215(1):127–34.
   PubMed Web of Science ®Google Scholar
• Ortmann R. The conditioned place preference paradigm in rats: effect of bupropion. Life Sci. 1985;37(21):2021–27.
   PubMed Web of Science ®Google Scholar
• Nielsen JA, Shannon NJ, Bero L, Moore KE. Effects of acute and chronic bupropion on locomotor activity and dopaminergic neurons. Pharmacol Biochem Behav. 1986;24(4):795–99.
   PubMed Web of Science ®Google Scholar
• Soroko FE, Mehta NB, Maxwell RA, Ferris RM, Schroeder DH. Bupropion hydrochloride ((±) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent. J Pharm Pharmacol. 1977;29(12):767–70.
   PubMed Web of Science ®Google Scholar
• Redolat R, Vidal J, Gomez MC, Carrasco MC. Effects of acute bupropion administration on locomotor activity in adolescent and adult mice. Behav Pharmacol. 2005;16(1):59–62.
   PubMed Web of Science ®Google Scholar
• Wilkinson JL, Bevins RA. Bupropion hydrochloride produces conditioned hyperactivity in rats. Physiol Behav. 2007;90(5):790–96. doi:10.1016/j.physbeh.2007.01.003.
   PubMed Web of Science ®Google Scholar
• Jones CN, Howard JL, McBennett ST. Stimulus properties of antidepressants in the rat. Psychopharmacology. 1980;67(2):111–18.
   PubMed Web of Science ®Google Scholar
• Katz JL, Izenwasser S, Terry P. Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects. Psychopharmacology. 2000;148(1):90–98.
   PubMed Web of Science ®Google Scholar
• Blitzer RD, Becker RE. Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism. Psychopharmacology. 1985;85(2):173–77.
   PubMed Web of Science ®Google Scholar
• Broadbent J, Gaspard TM, Dworkin SI. Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids. Pharmacol Biochem Behav. 1995;51(2–3):379–85.
   PubMed Web of Science ®Google Scholar
• Desai RI, Barber DJ, Terry P. Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats. Psychopharmacology. 2003;167(4):335–43. doi:10.1007/s00213-003-1426-x.
   PubMed Web of Science ®Google Scholar
• Quinton MS, Gerak LR, Moerschbaecher JM, Winsauer PJ. Effects of pregnanolone in rats discriminating cocaine. Pharmacol Biochem Behav. 2006;85(2):385–92. doi:10.1016/j.pbb.2006.09.006.
   PubMed Web of Science ®Google Scholar
• Lamb RJ, Griffiths RR. Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine. Psychopharmacology. 1990;102(2):183–90.
   PubMed Web of Science ®Google Scholar
• Kleven MS, Anthony EW, Woolverton WL. Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther. 1990;254(1):312–17.
   PubMed Web of Science ®Google Scholar
• Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther. 1989;251(1):150–55.
   PubMed Web of Science ®Google Scholar
• Spealman RD, Madras BK, Bergman J. Effects of cocaine and related drugs in nonhuman primates. J Pharmacol Exp Ther. 1989;251(1):142–49.
   PubMed Web of Science ®Google Scholar
• Terry P, Katz JL. Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats. Psychopharmacology. 1997;134(2):201–12.
   PubMed Web of Science ®Google Scholar
• Johanson CE, Barrett JE. The discriminative stimulus effects of cocaine in pigeons. J Pharmacol Exp Ther. 1993;267(1):1–8.
   PubMed Web of Science ®Google Scholar
• Munzar P, Goldberg SR. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats. Psychopharmacology. 2000;148(2):209–16.
   PubMed Web of Science ®Google Scholar
• Banks ML, Smith DA, Blough BE. Methamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeys. Behav Pharmacol. 2016;27(2–3 Spec Issue):196–203. doi:10.1097/FBP.0000000000000224.
   PubMed Web of Science ®Google Scholar
• Sasaki JE, Tatham TA, Barrett JE. The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology. 1995;120(3):303–10.
   PubMed Web of Science ®Google Scholar
• Young R, Glennon RA. Nicotine and bupropion share a similar discriminative stimulus effect. Eur J Pharmacol. 2002;443(1–3):113–18.
   PubMed Web of Science ®Google Scholar
• Shoaib M, Sidhpura N, Shafait S. Investigating the actions of bupropion on dependence-related effects of nicotine in rats. Psychopharmacology. 2003;165(4):405–12. doi:10.1007/s00213-002-1277-x.
   PubMed Web of Science ®Google Scholar
• Jl W, Kl L, Br M, Mi D. Nicotine-like discriminative stimulus effects of bupropion in rats. Exp Clin Psychopharmacol. 2002;10(2):129–35.
   PubMed Web of Science ®Google Scholar
• Cunningham CS, Javors MA, McMahon LR. Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys. J Pharmacol Exp Ther. 2012;341(3):840–49. doi:10.1124/jpet.112.193078.
   PubMed Web of Science ®Google Scholar
• Marusich JA, Lefever TW, Novak SP, Blough BE, Wiley JL. Prediction and Prevention of Prescription Drug Abuse: role of Preclinical Assessment of Substance Abuse Liability. Methods Rep RTI Press. 2013; RTI Press Publication No. OP-0014-1307:1–14.
   Google Scholar
• Tella SR, Ladenheim B, Cadet JL. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. J Pharmacol Exp Ther. 1997;281(1):508–13.
   PubMed Web of Science ®Google Scholar
• Mori T, Shibasaki M, Ogawa Y, Hokazono M, Wang T-C, Rahmadi M, Suzuki T. Comparison of the behavioral effects of bupropion and psychostimulants. Eur J Pharmacol. 2013;718(1):370–75. doi:10.1016/j.ejphar.2013.07.046.
   PubMed Web of Science ®Google Scholar
• Rush CR, Kollins SH, Pazzaglia PJ. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol. 1998;6(1):32–44.
   PubMed Web of Science ®Google Scholar
• Zernig G, De Wit H, Telser S, Nienhusmeier M, Wakonigg G, Sturm K, Berger I, Kemmler G, Saria A. Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting. Pharmacology. 2004;70(4):206–15. doi:10.1159/000075550.
   PubMed Web of Science ®Google Scholar
• Miller L, Griffith J. A comparison of bupropion, dextroamphetamine, and placebo in mixed-substance abusers. Psychopharmacology. 1983;80(3):199–205.
   PubMed Web of Science ®Google Scholar
• Griffith JD, Carranza J, Griffith C, Miller LL. Bupropion: clinical assay for amphetamine-like abuse potential. J Clin Psychiatry. 1983;44(5 Pt 2):206–08.
   PubMed Web of Science ®Google Scholar
• Hamilton MJ, Smith PR, Peck AW. Effects of bupropion, nomifensine and dexamphetamine on performance, subjective feelings, autonomic variables and electroencephalogram in healthy volunteers. Br J Clin Pharmacol. 1983;15(3):367–74.
   PubMed Web of Science ®Google Scholar
• Chevassus H, Farret A, Gagnol JP, Poncon CA, Costa F, Roux C, Galtier F, Petit P. Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155). Eur J Clin Pharmacol. 2013;69(4):779–87. doi:10.1007/s00228-012-1418-z.
   PubMed Web of Science ®Google Scholar
• Steele LS, Macdonald EM, Gomes T, Hollands S, Paterson JM, Mamdani MM, Juurlink DN. Rates of Anomalous Bupropion Prescriptions in Ontario, Canada. Ann Fam Med. 2015;13(4):343–46. doi:10.1370/afm.1818.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2010: national Estimates of Drug-Related Emergency Department Visits. HHS publication no(SMA) 12-4733 2012;DAWN Series D(38).
   Google Scholar
• Bibeau K, Henegar C Assessment of Bupropion Misuse and Abuse 2004-2011. Worldwide Epidemiology Final Study Report. GlaxoSmithKline; 2015. Contract No.: PRJ2215.
   Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA). 2015 National Survey on Drug Use and Health (NSDUH): detailed Tables. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2016.
   Google Scholar
• Rostas A, Wolf U. Bupropion abuse resulting in hypomania in a geriatric amphetamine user: A case report. Am J Addict. 2015;24(8):765–66. doi:10.1111/ajad.12308.
   PubMed Web of Science ®Google Scholar
• Vento AE, Schifano F, Gentili F, Pompei F, Corkery JM, Kotzalidis GD, Girardi P. Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse. Annali dell’Istituto Superiore Di Sanita. 2013;49(4):402–05. doi:10.4415/ANN_13_04_14.
   PubMed Web of Science ®Google Scholar
• Hill S, Sikand H, Lee J. A case report of seizure induced by bupropion nasal insufflation. Prim Care Companion J Clin Psychiatry. 2007;9(1):67–69.
   PubMedGoogle Scholar
• Langguth B, Hajak G, Landgrebe M, Unglaub W. Abuse potential of bupropion nasal insufflation: a case report. J Clin Psychopharmacol. 2009;29(6):618–19. doi:10.1097/JCP.0b013e3181c09475.
   PubMed Web of Science ®Google Scholar
• Kim D, Steinhart B. Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. Cjem. 2010;12(2):158–61.
   PubMedGoogle Scholar
• Reeves RR, Ladner ME. Additional evidence of the abuse potential of bupropion. J Clin Psychopharmacol. 2013;33(4):584–85. doi:10.1097/JCP.0b013e318295fe2f.
   PubMed Web of Science ®Google Scholar
• Yoon G, Westermeyer J. Intranasal bupropion abuse: case report. Am J Addict. 2013;22(2):180. doi:10.1111/vsu.v22.2.
   PubMed Web of Science ®Google Scholar
• Oppek K, Koller G, Zwergal A, Pogarell O. Intravenous administration and abuse of bupropion: a case report and a review of the literature. J Addict Med. 2014;8(4):290–93. doi:10.1097/ADM.0000000000000044.
   PubMed Web of Science ®Google Scholar
• Strike M, Hatcher S. Bupropion injection resulting in tissue necrosis and psychosis: previously undocumented complications of intravenous bupropion use disorder. J Addict Med. 2015;9(3):246–50. doi:10.1097/ADM.0000000000000114.
   PubMed Web of Science ®Google Scholar
• Stassinos GL, Bupropion K-SW. “Abuse” Reported to US Poison Centers. J Addict Med. 2016;10(5):357–62. doi:10.1097/ADM.0000000000000249.
   PubMed Web of Science ®Google Scholar
• Hilliard WT, Barloon L, Farley P, Penn JV, Koranek A. Bupropion diversion and misuse in the correctional facility. J Correct Health Care. 2013;19(3):211–17. doi:10.1177/1078345813486448.
   PubMed Web of Science ®Google Scholar
• Del Paggio D. Psychotropic medication abuse by inmates in correctional facilities. Mental Health Clinician. 2012;1(8):187–88. doi:10.9740/mhc.n95631.
   Google Scholar
• Lewis JC, Sutter ME, Albertson TE, Owen KP, Ford JB. An 11-year review of bupropion insufflation exposures in adults reported to the California Poison Control System. Clin Toxicol (Phila). 2014;52(9):969–72. doi:10.3109/15563650.2014.969372.
   PubMed Web of Science ®Google Scholar
• 2ton. Smoking Failure: an Experience with Bupropion (Wellbutrin) (exp30057): erowid.org; [ accessed 2006 Jun 17]. http://www.erowid.org/exp/30057.
   Google Scholar
• McCormick J. Recreational bupropion abuse in a teenager. Br J Clin Pharmacol. 2002;53(2):214. doi:10.1046/j.0306-5251.2001.01538.x.
   PubMed Web of Science ®Google Scholar
• Costa C, Araujo A, Brasil M, Cruz M. Possible addiction transference from cocaine insufflation to oral bupropion in bipolar patient. J Addict Med. 2015;9(2):155–56. doi:10.1097/ADM.0000000000000098.
   PubMed Web of Science ®Google Scholar
• Rahman S, Mohiuddin S, Hua L. Seizures secondary to bupropion misuse/abuse: three cases. Adolescent Psychiatry. 2013;3(2):208–11. doi:10.2174/2210676611303020013.
   Google Scholar
• Welsh CJ, Doyon S. Seizure induced by insufflation of bupropion. N Engl J Med. 2002;347(12):951. doi:10.1056/NEJM200209193471222.
   PubMed Web of Science ®Google Scholar
• Khurshid KA, Decker DH. Bupropion insufflation in a teenager. J Child Adolesc Psychopharmacol. 2004;14(1):157–58. doi:10.1089/104454604773840634.
   PubMed Web of Science ®Google Scholar
• Baribeau D, Araki KF. Intravenous bupropion: a previously undocumented method of abuse of a commonly prescribed antidepressant agent. J Addict Med. 2013;7(3):216–17. doi:10.1097/ADM.0b013e3182824863.
   PubMed Web of Science ®Google Scholar
• Zaphod. Not so fun high: an experience with bupropion (exp106254): erowid.org; [ accessed 2016 Feb 11]. http://www.erowid.org/exp/106254.
   Google Scholar
• Sam. Shaddows: an experience with bupropion (Wellbutrin XL) & Cannabis (exp66652): erowid.org; [ accessed 2011 Jan 1]. http://www.erowid.org/exp/66652.
   Google Scholar
• Devil T A guy with no face at my window: an experience with bupropion (Wellbutrin) (exp64818): erowid.org; [ accessed 2009 Oct 6]. http://www.erowid.org/exp/64818.
   Google Scholar
• Epidemic. Blue Smiley Faces: an Experience with Bupropion (Wellbutrin) (exp49536): erowid.org; [ accessed 2008 Mar 19]. http://www.erowid.org/exp/49536.
   Google Scholar
• Marc. Just Weird: an Experience with Bupropion (Wellbutrin) (exp42830): erowid.org; [ accessed 2008 Jul 13]. http://www.erowid.org/exp/42830.
   Google Scholar
• Samantha. Nothing Special: an Experience with Bupropion (exp67925): erowid.org; [ accessed 2008 Jan 10]. http://www.erowid.org/exp/67925.
   Google Scholar
• Elli P Hallucinations Yes, Spirtual No: an Experience with Bupriopion (Wellbutrin) (exp52995): erowid.org; [ accessed 2008 Mar 25]. http://www.erowid.org/exp/52995.
   Google Scholar
• MJ. Prescription for Hallucination: an Experience with Bupropion (Wellbutrin) (exp41444): erowid.org; [ accessed 2008 Jul 15]. http://www.erowid.org/exp/41444.
   Google Scholar
• Super_Thrasher. Mice in the Door: an Experience with Bupropion (exp61278): erowid.org; [ accessed 2008 May 20. http://www.erowid.org/exp/61278.
   Google Scholar
• tooth. Grand Mal Seizure Not Fun: an Experience with Bupropion (exp58847): erowid.org; [ accessed 2007 Jan 17] http://www.erowid.org/exp/58847.
   Google Scholar
• anon. No High and a Near Death Experience: an Experience with Bupropion (Wellbutrin) (exp61164): erowid.org; [ accessed 2007 Mar 6]. http://www.erowid.org/exp/61164.
   Google Scholar
• cRUNk4L1f3. No Fun: an Experience with Bupropion (Wellbutrin) (exp53551): erowid.org; [ accessed 2008 Oct 30]. http://www.erowid.org/exp/53551.
   Google Scholar
• Rebecca. Worst Night of My Life: an Experience with Bupropion (Wellbutrin) (exp36326): erowid.org; [ accessed 2006 Sep 25]. http://www.erowid.org/exp/36326.
   Google Scholar
• Andrew. Two Days after Overdose, Heart Rate Still Fast: an Experience with Bupropion (Wellbutrin) (exp38483): erowid.org; [ accessed 2005 Jan 3]. http://www.erowid.org/exp/38483.
   Google Scholar
• Pointless. Floatiness and Vivid Imagination: an Experience with Bupropion (exp21704): erowid.org; [ accessed 2006 Apr 10]. http://www.erowid.org/exp/21704.
   Google Scholar
• Tir. Too Much Bupropion: an Experience with Bupropion (Wellbutrin) (exp15844): erowid.org; [ accessed 2002 Jul 11]. http://www.erowid.org/exp/15844.
   Google Scholar
• WhiteRook. Dangers With Insufflation: an Experience with Bupropion (exp99595): erowid.org; [ accessed 2016 Feb 10]. http://www.erowid.org/exp/99595.
   Google Scholar
• Nat. Won’t Be Doing This Again: an Experience with Bupropion (exp98113): erowid.org; [ accessed 2012 Nov 29]. http://www.erowid.org/exp/98113.
   Google Scholar
• Yurt. My Nose Is on Fire: an Experience with Bupropion (Wellbutrin) (exp55685): erowid.org; [ accessed 2011 Jan 1]. http://www.erowid.org/exp/55685.
   Google Scholar
• Not RDS Dissimilar to Cocaine: an Experience with Bupropion (Wellbutrin) (exp82758): erowid.org; [ accessed 2009 Dec 14]. http://www.erowid.org/exp/82758.
   Google Scholar
• Chris. Mildly Pleasant: an Experience with Bupropion (Wellbutrin) (exp42974): erowid.org; [ accessed 2008 Aug 29]. http://www.erowid.org/exp/42974.
   Google Scholar
• Kijuro. Painfully Euphoric: an Experience with Bupropion (Wellbutrin XL) (exp43733): erowid.org; [ accessed 2008 Sep 10. http://www.erowid.org/exp/43733.
   Google Scholar
• Jezebel. Dreamy Euphoric State: an Experience with Bupropion (Wellbutrin), Aripiprazole (Abilify) & Escitalopram (Lexapro) (exp28782): erowid.org; [ accessed 2007 Aug 21]. http://www.erowid.org/exp/28782.
   Google Scholar
• Pharmtard. The higher I Go, The Lower I Stay: an Experience with Bupropion & Various (exp42074): erowid.org; [ accessed 2007 Aug 2]. http://www.erowid.org/exp/42074.
   Google Scholar
• Cutlutch. Happiness and Despair: an Experience with Bupropion (exp18418): erowid.org; [ accessed 2005 Sep 22]. http://www.erowid.org/exp/18418.
   Google Scholar
• Batman. Increased Awareness: an Experience with Bupropion (Wellbutrin) (exp20042): erowid.org; [ accessed 2005 Sep 29]. http://www.erowid.org/exp/20042.
   Google Scholar
• DopamineHead. Not Worth It at All: an Experience with Bupropion (Wellbutrin) (exp35089): erowid.org; [ accessed 2004 Jul 12]. http://www.erowid.org/exp/35089.
   Google Scholar
• witty. Vibration Noise: an Experience with Bupropion (Wellbutrin) (exp35088): erowid.org; [ accessed 2004 Jul 12]. http://www.erowid.org/exp/35088.
   Google Scholar
• cowboy d. Snorting Wellbutrin: an Experience with Bupropion (exp9266): erowid.org; [ accessed 2001 Sep 6]. http://www.erowid.org/exp/9266.
   Google Scholar